map2 (Cell Signaling Technology Inc)
Structured Review

Map2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 108 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti+map2/pmc12751141-40-7-12?v=Cell+Signaling+Technology+Inc
Average 93 stars, based on 108 article reviews
Images
1) Product Images from "Disrupting α-Synuclein–ClpP interaction restores mitochondrial function and attenuates neuropathology in Parkinson’s disease models"
Article Title: Disrupting α-Synuclein–ClpP interaction restores mitochondrial function and attenuates neuropathology in Parkinson’s disease models
Journal: Molecular Neurodegeneration
doi: 10.1186/s13024-025-00918-w
Figure Legend Snippet: CS2 treatment is protective in DA neurons derived from PD patient iPSCs. ( A ) Representative images of MitoTracker staining and ClpP-αSyn PLA in A53T αSyn or isogenic control (ISO) iPSCs-derived neurons (scale bar = 30 μm). ( B ) Representative images of ClpP-αSyn PLA in A53T αSyn or ISO iPSCs-derived neurons, which were treated with TAT or CS2 peptide (scale bar = 30 μm). Quantification of the average PLA puncta number in neurons ( n = 20 images per group, one-way ANOVA with Tukey’s post-hoc test; data are mean ± SEM). ( C ) Representative blots of co-immunoprecipitation assay assessing ClpP-αSyn in A53T αSyn or ISO iPSCs-derived neurons, which were treated with TAT or CS2 peptide. Normalized ratio of ClpP to αSyn was shown in histogram ( n = 4, one-way ANOVA with Tukey’s post-hoc test; data are mean ± SEM). ( D ) Representative images of ClpP staining in tyrosine dehydrogenase positive (TH + ) iPSCs-derived DA neurons treated with TAT or CS2 peptide (scale bar = 30 μm). Quantification of ClpP intensity in TH + neurons ( n = 6, one-way ANOVA with Tukey’s post-hoc test; data are mean ± SEM). ( E ) Representative images of pS129-αSyn (pS129) staining in TH + iPSCs-derived DA neurons treated with TAT or CS2 peptide (scale bar = 30 μm). Quantification of pS129 intensity in TH + neurons ( n = 5–7, one-way ANOVA with Tukey’s post-hoc test; data are mean ± SEM). ( F ) Representative images of PSD95, Synapsin1 (SYN1) and MAP2 staining in iPSCs-derived neurons treated with TAT or CS2 peptide (scale bar = 30 μm). Quantification of the intensity of dendritic PSD95 and SYN1 ( n = 6–7, one-way ANOVA with Tukey’s post-hoc test; data are mean ± SEM)
Techniques Used: Derivative Assay, Staining, Control, Co-Immunoprecipitation Assay
